Zaena Bio Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -36.78%
(FY 2019)
- Profit -51.62%
(FY 2019)
- Ebitda -125.07%
(FY 2019)
- Net Worth 10.26%
(FY 2019)
- Total Assets 36.73%
(FY 2019)
About Zaena Bio
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohamed Bibi and Mohamed Sardhaz serve as directors at the Company.
- CIN/LLPIN
U01100TZ2017PTC028686
- Company No.
028686
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zaena Bio Private Limited offer?
Zaena Bio Private Limited offers a wide range of products and services, including Water Treatment & Purification Plant, STP & ETP Tools, Insecticides and Pesticides, Biofungicides, Fertilizers and Soil Additives, Organic Fertilizers and Manure, Nitrogen Fertilizers, Bio Insecticides, Insecticides, Medical Surgery & Treatment Centres.
Who are the key members and board of directors at Zaena Bio?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Sardhaz  | Managing Director | 24-Mar-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohamed Bibi | Director | 24-Mar-2017 | Current |
Financial Performance of Zaena Bio.
Zaena Bio Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 36.78% decrease. The company also saw a substantial fall in profitability, with a 51.62% decrease in profit. The company's net worth Soared by an impressive increase of 10.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zaena Bio?
Unlock access to Zaena Bio's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zaena Bio?
Unlock and access historical data on people associated with Zaena Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zaena Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zaena Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
